Ministry of Health and Family Welfare
Total Recoveries in India surpass 26 lakh
Increasing Recovery Rate is coupled with a consistently falling Case Fatality
Rate
Posted On: 29 AUG 2020 4:10PM by PIB Delhi
A significant feature of India’s
management of COVID-19 cases is the growing rate of recovered patients.
Higher number of patients are recovering and being discharged from hospitals
and home isolation (in case of mild and moderate cases). These recoveries are
being achieved because of adherence to the “National Standard Treatment
Protocol” by all health facilities across the country as well as by regular
daily monitoring of positive cases under home isolation.
The COVID-19 recoveries have
crossed 26 lakh today. Recovery of 2,648,998patients has been made possible
because of the holistic and strategic policy of TESTING aggressively, TRACKING
comprehensively & TREATING efficiently in supervised home isolation and facility
isolation, and in hospitals.
65,050 recoveries have been registered
in the last 24 hours. The Centre has been regularly interacting with States
that are showing higher fatality rates. There is a sharp focus on skilled
doctors to man the ICUs. AIIMS New Delhi through its tele-consultation sessions
every Tuesday and Friday is building the clinical treatment capabilities and
skills of the doctors in the States/UTs. With better ambulance services
ensuring reduced response time, focus on Standard of Care and use of
non-invasive oxygen, steroids and anti- coagulants, the Recovery Rate has now
reached76.47%. As a result, the Case Fatality
Rate (CFR) has also been low when compared to the global average. It is on a
continuous decline and currently stands at 1.81%.
The Recovery Rate of India is
following a continuous upward incline whereas the Case Fatality Rate is
constantly declining.
The actual case load of the
country is the active cases (752,424) which is only 21.72%of the total positive cases.
They are under active medical supervision. With a consistent and sustained
increase in recoveries, the gap between recovered patients and active COVID-19
cases reach nearly 19 lakh.
For all authentic & updated information on COVID-19
related technical issues, guidelines & advisories please regularly visit:
https://www.mohfw.gov.in/ and @MoHFW_INDIA.
Technical queries related to COVID-19 may be sent to technicalquery.covid19@gov.in
and other queries on ncov2019@gov.in and @CovidIndiaSeva .
In case of any queries on COVID-19, please call at the
Ministry of Health & Family Welfare helpline no.: +91-11-23978046 or 1075
(Toll-free). List of helpline numbers of States/UTs on COVID-19 is also
available at
https://www.mohfw.gov.in/pdf/coronvavirushelplinenumber.pdf
****
MV/SJ
(Release ID: 1649487) Visitor Counter : 199
Ministry of Health and Family Welfare
Unprecedented upsurge in testing, India crosses a new
peak of 4 cr tests
More than 9 lakh tests conducted for third successive day
Posted On: 29 AUG 2020 12:29PM by PIB Delhi
In its fight against COVID-19
since January 2020, India has crossed another peak. The cumulative tests have
seen an unprecedented upsurge and surpassed 4 crore today.
With focussed, consistent and
coordinated efforts led by the Centre and implemented by the State/UT
governments, India has set a new landmark of testing 4,04,06,609 people. India has come a
long way from conducting just one test from the lab in Pune in January 2020 to
crossing 4 crore tests milestone.
The single day tests have also
seen a upsurge. Already having achieved the testing capacity of 10 laks tests
per day, 9,28,761 tests conducted in the
last 24 hours.
This has boosted the Tests Per
Million (TPM) with a sharp increase to 29,280. As is seen in many States/UTs
that have increased the testing, the positivity rate will eventually fall with
higher levels of testing. The national positivity rate has remained low i.e. 8.57% and is constantly falling.
India is fallowing the strategic
approach of TEST, TRACK, TREAT where testing forms the initial and crucial
pillar of COVID response and management. It is only by aggressive testing that
positive cases are identified at an early stage, their close contacts can be
promptly tracked and isolated, and timely and effective treatment can be
ensured for those in home isolation and the ones hospitalised.
Expanded diagnostic lab network
and facilitation for easy testing across the country through several policy
measures have given a substantial boost to this upsurge in national testing
rates. There are as many as 1576 labs in the country; 1002 labs in the
government sector and 574 private labs. These include:
• Real-Time
RT PCR based testing labs: 806 (Govt: 462 + Private: 344)
• TrueNat based testing labs: 650
(Govt: 506 + Private: 144)
• CBNAAT based testing labs: 120
(Govt: 34 + Private: 86)
For all authentic & updated
information on COVID-19 related technical issues, guidelines & advisories
please regularly visit: https://www.mohfw.gov.in/ and @MoHFW_INDIA.
Technical queries related to
COVID-19 may be sent to technicalquery.covid19@gov.in and other queries on
ncov2019@gov.in and @CovidIndiaSeva .
In case of any queries on
COVID-19, please call at the Ministry of Health & Family Welfare helpline
no.: +91-11-23978046 or 1075 (Toll-free). List of helpline numbers of
States/UTs on COVID-19 is also available at https://www.mohfw.gov.in/pdf/coronvavirushelplinenumber.pdf.
****
MV/SJ
HFW/COVID Tests/29Aug2020/1
(Release ID: 1649449) Visitor Counter : 136
Ministry of Health and Family Welfare
Dr Harsh Vardhan chairs 20th meeting of Group of
Ministers (GOM) on COVID-19
India has one of the lowest global COVID fatality rates: Dr Harsh Vardhan
Dr. Vinod Paul, Member (Health) NitiAayog apprises GoM on Vaccine Development
in India
Posted On: 29 AUG 2020 3:36PM by PIB Delhi
Dr. Harsh Vardhan, Union Minister of Health & Family
Welfare chaired the 20th meeting of the high-level Group of Ministers (GoM) on
COVID-19, here today. He was joined by Dr S. Jaishankar, Minister of External
Affairs, Sh. Hardeep S. Puri, Minister of Civil Aviation, Sh.
MansukhLalMandaviya, Minister of State, Shipping (Independent Charge),
Chemicals and Fertilizers, Sh. Ashwini Kumar Choubey, Minister of State, Health
& Family Welfare and Sh. NityanandRai, Minister of State, Home Affairs. Dr.
Vinod Paul, Member (Health) NitiAayog, joined virtually.
At the outset, Dr. Harsh Vardhan expressed satisfaction
at the various coordinated efforts of the Centre Government and those of the
States/UTs. He stated “In the month since the last meeting of GoM on 31st July,
we have made tremendous strides in containing the disease. As many as 26.4
lakhhave already recovered. The country’s Case Fatality Rate is at its lowest
1.81% and consecutively Recovery Rate has increased to 76.47%.” He further
informed the GOM that with creation of sufficient health facilities, the health
infrastructure in the country has been amply strengthened. Also, only
0.29% of cases are on ventilators, 1.93% on ICU and only 2.88% of cases are on
oxygen. A total of 1576 labs at present have led to an upsurge in testing and
the goal of 10 lakhs tests per day has been fulfilled. More than 9 lakh samples
were tested in the last 24 hours and this has led to the cumulative total
number of tests crossing the 4 crore mark” he added. Dr Harsh Vardhan also
informed the GOM that more than 338 lakhs of N-95 masks, nearly 135 lakh of
PPEs and about 27,000 ventilators have been provided by the centre to the
States/UTs.
The Union Health Minister instructed the Health Ministry
to develop SOPs for the Members of Parliament and the Legislative Assembly
sessions comprising COVID protocols and preventive measures. The GOM also
expressed concern about the forthcoming festival seasons and advised everyone
to adopt safe and COVID appropriate behaviour.
The GoM was briefed on the current status of COVID-19 in
India. The global comparison clearly depicted that India has one of the lowest
cases per million (2424) and deaths per million (44) compared to the global
average of 3161 and 107.2 respectively. It was noted that despite being
resource constrained and densely populated, timely lockdown and rapid
augmentation of infrastructure by India have enabled to keep the case/ million
and deaths/million considerably lower compared to other countries. Within the
country, eight States (Maharashtra, Karnataka, Andhra Pradesh, Tamil Nadu,
Uttar Pradesh, West Bengal, Odisha and Telangana) contribute to around 73% of
the active caseload, as of today. Moreover, seven States (Maharashtra, Delhi,
Tamil Nadu, Andhra Pradesh, Karnataka, Uttar Pradesh and West Bengal) account
for 81% of total deaths. The GoM was briefed on the guidance note issued on the
bi-directional TB and COVID screening, diabetes management in COVID facilities,
etc., and the meeting chaired by Cabinet Secretary with the States where they
were advised to ramp up testing and measures were suggested to contain the
spread and reduce mortality below 1%.
Dr. Sujit Singh, Director (NCDC) presented a detailed
report on surveillance efforts undertaken in India during the pandemic through
the IDSP (Integrated Disease Surveillance Programme) network. He highlighted
the challenges faced and the learnings from the various States. He also threw light
on the trajectory of COVID in some States and elaborated on their response and
management. The major concern areas in the country were highlighted. It
was mentioned that there needs to be continued attention on promotion of
wearing of masks, physical distancing and respiratory etiquettes. Behaviour
change communication therefore assumes priority role in COVID management.
Dr. Vinod K Paul, Chairperson of the Empowered Group-1
on Medical Emergency management plan apprised the GoM of the process of COVID
vaccine development in India and around the world. He stated that 29
candidates, including 2 Indian ones, are in Clinical Trials out of which 6 are
in Phase III. In India, Bharat Biotech’s vaccine candidate based on inactivated
virus procured by ICMR is in Phase II trial along with ZydusCadila’s candidate
which is based on viral DNA. The Oxford vaccine candidate developed by Serum
Institute of India is already in Phase III trial in Maharashtra and some other
States. Dr. Paul also informed the GoMof the progress made by the National
Expert Group on Vaccine Administration for COVID-19. The group is tasked with
facilitation of vaccine development including issues of trial and stockpiling,
sorting out issues of financing, risk-management, selection of potential
beneficiaries and their order of reference, envisioning logistics, scale up,
digital system, defining principles for selecting beneficiary categories, and
defining scientific basis for selecting vaccine. Three meetings of the Expert
Group have been held so far.
Sh. Rajesh Bhushan, Health Secretary apprised the GOM on
the efforts made by the Health Ministry towards mental health during the
pandemic. He also stated that the Central Government was in direct
communication with the States that were reporting a surge in cases and those
with higher mortality rates. These were being guided towards measures that
would result in saving lives and speedy recoveries.
Sh. Ravi Capoor, Secretary (Textiles), Sh. Amitabh Kant,
CEO, NitiAayog,Dr.BalramBhargava, DG (ICMR), Sh.
AmitYadav, DG, Foreign Trade (DGFT), Sh. Anil Malik, Addl.
Secretary (Home Affairs), ShriDammu Ravi, AddlSecy (MEA), and other
senior government officials including representatives of ITBP HQ participated
through virtual media.
****
MV/SJ
(Release ID: 1649481) Visitor Counter : 109
No comments:
Post a Comment